date:Feb 28, 2014
Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it intends to repurchase 2,500,000 ordinary shares, starting on 27 February 2014, in order to cover its commitments under existing management and personnel option plans. Based on the closing price of the DSM share on Euronext Amsterdam on 26 February 2014 this would be equivalent to approximately 120 million.
This share repurchase program is anticipated to continue into Q2 2014 and is the second and final p